Soligenix Stock Fundamentals

SNGX Stock  USD 2.40  0.05  2.13%   
Soligenix fundamentals help investors to digest information that contributes to Soligenix's financial success or failures. It also enables traders to predict the movement of Soligenix Stock. The fundamental analysis module provides a way to measure Soligenix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Soligenix stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Soligenix Company Return On Equity Analysis

Soligenix's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Soligenix Return On Equity

    
  -1.4  
Most of Soligenix's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Soligenix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Soligenix has a Return On Equity of -1.398. This is 94.17% lower than that of the Biotechnology sector and 96.17% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

Soligenix Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Soligenix's current stock value. Our valuation model uses many indicators to compare Soligenix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Soligenix competition to find correlations between indicators driving Soligenix's intrinsic value. More Info.
Soligenix is rated below average in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Soligenix's earnings, one of the primary drivers of an investment's value.

Soligenix Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Soligenix's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Soligenix could also be used in its relative valuation, which is a method of valuing Soligenix by comparing valuation metrics of similar companies.
Soligenix is currently under evaluation in return on equity category among its peers.

Soligenix Fundamentals

About Soligenix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Soligenix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Soligenix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Soligenix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey. Soligenix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Soligenix Stock Analysis

When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.